Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | FEN1 | P39748 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | PDE4A | P27815 | 7/20 | 0.40 |
| ▸ | PDE4B | Q07343 | 6/20 | 0.40 |
| ▸ | PDE4C | Q08493 | 6/20 | 0.40 |
| ▸ | PDE4D | Q08499 | 6/20 | 0.40 |
| ▸ | PDE1A | P54750 | 1/20 | 0.37 |
| ▸ | PDE1B | Q01064 | 1/20 | 0.37 |
| ▸ | LDHA | P00338 | 1/20 | 0.37 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25411642 | 0.95 | ALDH1A1 (0.44) | KDM4EATML3MBTL1FEN1ALDH1A1 | |
| SCHEMBL25847041 | 0.93 | KDM4E (0.53) | KDM4EATML3MBTL1FEN1ALDH1A1 | |
| SCHEMBL26329901 | 0.92 | KDM4E (0.38) | KDM4EATML3MBTL1FEN1ALDH1A1 | |
| SCHEMBL26329814 | 0.90 | KDM4E (0.50) | KDM4EATML3MBTL1FEN1ALDH1A1 | |
| SCHEMBL26329910 | 0.90 | KDM4E (0.42) | KDM4EATML3MBTL1FEN1ALDH1A1 | |
| SCHEMBL26329921 | 0.90 | KDM4E (0.42) | KDM4EATML3MBTL1FEN1ALDH1A1 | |
| SCHEMBL20184179 | 0.90 | KDM4E (0.47) | KDM4EATML3MBTL1FEN1ALDH1A1 | |
| SCHEMBL16769859 | 0.90 | KDM4E (0.47) | KDM4EATML3MBTL1FEN1ALDH1A1 | |
| SCHEMBL17676387 | 0.89 | KDM4E (0.49) | KDM4EATML3MBTL1FEN1ALDH1A1 | |
| SCHEMBL26329788 | 0.89 | KDM4E (0.49) | KDM4EATML3MBTL1FEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11723269-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-08-08 | — | — | US | disclosed |
| US-11723269-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-08-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11723269-B2 | Organic electroluminescent materials and devices | PUF60, CD99, DDT | KDM4E 3163/4885ATM 3362/4885L3MBTL1 1292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.